Related Experiment Video
Updated: Jul 30, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
S-18886 Servier
Stavros K Kakkos1, Andrew N Nicolaides
1Irvine Laboratory for Cardiovascular Investigation and Research, Department of Vascular Surgery, Faculty of Medicine, Imperial College of Science, Technology and Medicine, 10th Floor QEQM Wing, St Mary's Hospital, London, W2 1NY, UK. s.kakkos@ic.ac.uk
Abstract:
S-18886, the active isomer of S-18204, is a thromboxane A2 receptor antagonist with a long duration of action. The compound is under development by Servier for the potential treatment of cardiovascular diseases [269611]. By 2000, a clinical trial had been carried out in patients with coronary artery disease [389458]; advanced clinical trials were ongoing in August 2001 [420310].
Related Concept Videos
Transport Number
Transmission of Pathogens

